JPRN-UMIN000002654Completed未知
A study of efficacy and safety of sertraline for the treatment of major depressive disorder patients, who have benn unremitted or intolerant by paroxetine or fluvoxamine - Efficacy of sertraline for SSRI non-remitted or intolerant cases
Hokkaido University Hospital, Department of Psychiatry0 sites140 target enrollmentStarted: October 26, 2009Last updated:
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 140
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 70years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1. severe physical diseases (heart, liver, kidney) 2. significant risk of suicide 3. under treatment with cognitvie-behavioral therapy of ECT 4. pregnant or breast-feeding women or women, who may be pregnant 5. organic brain disease 6. patients, whom investigaters regard as inapporopriate for subjects
Investigators
Similar Trials
Completed
Phase 2
Academic trial of sertraline in depressiomajor depressive disorderRPCEC00000128Dalhousie university, Halifax, Nova Scotia, Canada82
Recruiting
Phase 2
Evaluation of effectiveness of Sertraline and supportive psychotherapy on anxiety and depression levelIRCT20180425039418N4Zahedan University of Medical Sciences60
Not yet recruiting
Phase 2
Comparison of the effect of sertraline and midodrine in improving blood pressure during hemodialysisHypotension of hemodialysis.Hypotension of hemodialysisI95.3IRCT20100102002954N29Shahroud University of Medical Sciences82
Not yet recruiting
Phase 3
Effect of Sertraline in treatment of Covid-19IRCT20220110053681N1Sabzevar University of Medical Sciences60
Completed
Phase 3
Sertraline and Fluoxetin in Diabetic Patients with DepressioDiabetes Mellitus.Diabetes mellitus due to underlying conditionIRCT20150630022991N9Babol University of Medical Sciences40